About the Company
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end of 2021, and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NVAX News
What's Going On With Novavax Stock Today?
Novavax Inc (NASDAQ:NVAX) shares are trading higher Monday after Shah Capital Management reported a 6.66% stake in the ...
Novavax, Inc. (NVAX)
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in TD Cowen's 44th Annual Health Care Conference.
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
In a letter seen by MarketWatch, the activist fund blamed the sharp drop in Novavax’s sales on the U.S. vaccine-maker’s ...
Novavax comes under pressure from activist investor as COVID sales fall short
The investor has nominated Suresh Katta, founder and CEO of clinical analytics company Saama, and Venkat Peri, CEO of ...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are ...
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
Novavax has undertaken successive lay-off rounds as part of a $1.1bn cost cutting drive to stave off bankruptcy after it ...
Novavax (NASDAQ: NVAX)
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...
Shah Capital calls for board shake-up at Novavax
Shah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and failure to maximize ...
Novavax COVID jab delivered by indie pharmacy in UK first
The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent ...
Novavax Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...